Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
Background
Cited by
Items 601–637 of 637
Zhao, H., Shi, D., Wang, G., Ruan, Y., Feng, X., Jia, C., Wang, Q., & Dong, X. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231195627
HIPOGONADISMO MASCULINO E SUA RELAÇÃO COM A SINDROME METABÓLICA
Pinto, J. C., & da Costa, R. S. L. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n1-079 · Cited by 2
Male hypogonadism and its relationship with metabolic syndrome
Pinto, J. C., & da Costa, R. S. L. (2024) · Seven Editora eBooks · doi:10.56238/sevened2024.003-053
Recognising the true value of testosterone therapy in health care
Morgentaler, A., Traish, A. M., Barua, R., Dandona, P., Dhindsa, S., Khera, M., & Saad, F. (2023) · South African General Practitioner · doi:10.36303/sagp.0131
Self-citationNuovi farmaci antidiabete e ipogonadismo maschile
Carafa, A., & Maddaloni, E. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01541-5
“Nello stesso studio, circa un paziente su tre era affetto da ipogonadismo, e in più dell’80% dei casi si trattava di ipogonadismo ipo-gonadotropo [3, 4].”
Funktioneller Hypogonadismus: Diabetes mellitus, Adipositas, metabolisches Syndrom und Testosteron
Meirelles, R. M. D. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_8
Si, P. E. H., & Abdelhafiz, A. H. (2025) · Wiley eBooks · doi:10.1002/9781394205066.ch15
Metabolic intervention restores fertility and sperm health in non-obese diabetic rats
Tümentemur, G., Titiz, M., & Örs, A. B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1558769 · Cited by 1
“Due to the increasing incidence of morbid obesity, bariatric surgery, which has long-term effectiveness for weight loss, comorbidities, and mortality, has become an increasingly common form of treatment, especially in China (49 – 52).”
InfluentialHypogonadism in Men with Obesity and Type 2 Diabetes
Dhindsa, S., Ghanim, H., & Dandona, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_18
Self-citationMusa, E., Musa, G., Salazar‐Petres, E., Bello, F., & Bakari, A. G. (2025) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2025.2514412
Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats
Lu, C.-C., Chang, C.-H., Chou, J., Yu, P., & Wang, P. S. (2025) · Reproduction and Fertility · doi:10.1530/raf-24-0087
Sleep quality as a predictor of sexual dysfunction in men with type 2 diabetes
Srinivas, M. S., Shivam, S., Jain, T., Prahaladbhai, P. A., Devraj, S., Mohanty, L., & Das, S. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20252396
Leydig Cell Function in Obesity and Diabetes
Grossmann, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_34
Adeleye, J. O., Onasanya, A., Sonuga, O. O., Esan, A., & Adebiyi, A. A. (2025) · PubMed Central
Wu, W., Zeng, A., Yu, Y., Liao, L., Jiao, Y., Hu, J., & Chen, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03736-0
Wh, K., Kamaruddin, N. A., & Sukor, N. (2025) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.040.02.11
“1– 21 Hypogonadism among T2DM males has been strongly linked The T2DM diagnosis was based on the American Diabetes Association criteria of abnormal fasting blood glucose or modified oral glucose tolerate test (mOGTT) or HbA1c >6.3%.”
InfluentialUpplevelser av sexuell dysfunktion hos personer med diabetes typ 2
Mahmud, H., & Thulin, K. (2020) · Lund University Publications Student Papers (Lund University)
Investigating the white adipose tissue phenotype in the male and female Phb1-C69A knock-in mice
Bernier, K. (2024) · Mspace (University of Manitoba) · Cited by 2
El hipogonadismo masculino en pacientes con diabetes tipo 2
Knoblovits, P., & Costanzo, P. R. (2016) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v36i4.651
Garifalos, F., Menafra, D., de Angelis, C., Larocca, A., Virgolesi, M., Aprano, S., Luca, V. D., Rea, T., Attaianese, E., Perillo, M., et al. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1691309
“Interventional studies on testosterone replacement therapy (TRT) in hypogonadal men with obesity (25–31) and/or MetS or T2-DM (32–34) confirm improvements in anthropometric, lipid, and glycaemic parameters, reinforcing the association between testosterone deficiency and metabolic CVR factors (10).”
Gupta, H., Singh, R., Singh, K., Gupta, M., Kaur, J., Singla, M., & Garg, S. (2026) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_842_25
The Aging Male Endocrine System: Clinical Insights into Andropause Management
Garg, R. (2026) · Journal of The Indian Academy of Geriatrics · doi:10.4103/jiag.jiag_83_25
Sexual dysfunction in patients with Type 2 diabetes: A South Asian perspective
Selim, S. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102108
Prevalence of Serum Testosterone Deficiency in Type 2 Diabetes Mellitus
Varun, A., Kanakaraju, K., & Karthick, S. (2026) · Journal of the Indian Medical Association · doi:10.5005/jima-11070-0001
Male hypogonadism and incretin therapy response
Vignera, S. L., & Condorelli, R. A. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106948
Matrone, R., Caruso, P., Longo, M., Pontillo, A., Carbone, C., Cirillo, P., Porcellini, C., Tomasuolo, M., Scappaticcio, L., Maiorino, M. I., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02967-4
“In 2004, Dhindsa et al. described a frequent association between hypogonadotropic hypogonadism and type 2 diabetes (T2D) in males [4].”
Wazir, N., Khan, S., & Ubaid, M. (2026) · Journal of Postgraduate Medical Institute · doi:10.54079/jpmi.40.2.3516
Patel, M., Moreland, H., Anvar, A., Glover, F., Maremanda, A. P., Deebel, N. A., Halpern, J. A., & Brannigan, R. E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145718
“Hypogonadotropic hypogonadism and other broader HPG axis alterations that result from DM can also threaten male fertility more directly, as low testosterone can decrease spermatogenesis [20,21].”
Ntais, C., Vantarakis, A., & Chatziprodromidou, I. P. (2026) · Medical Sciences · doi:10.3390/medsci14030418 · Cited by 1
“…resistance, chronic low-grade inflammation, and reduced sex hormone-binding globulin (SHBG) can lower total testosterone, while suppression of hypothalamic–pituitary–gonadal signaling may reduce free testosterone and produce a functional, potentially reversible, secondary hypogonadal state [1,5,6].”
Gillman, N., & Chung, E. (2026) · Translational Andrology and Urology · doi:10.21037/tau-2026-1-0168
Mukherjee, A. G., Bharti, A. K., Mathew, D. M., Gopalakrishnan, A. V., & Nishu, S. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10274-9
“Long-standing diabetes is frequently associated with reduced circulating testosterone levels and dysregulation of the hypothalamic-pituitary-gonadal axis, a phenomenon consistently observed in men with insulin resistance (Dhindsa et al. 2004; Grossmann et al. 2008).”
Ožana, J., Moravcová, K., Adámek, R., & Sovová, E. (2026) · Cor et Vasa · doi:10.33678/cor.2026.014
de Figueiredo, A. B. (2022) · Revista Interdisciplinar de Pesquisa e Inovação
Menafra, D., de Angelis, C., Garifalos, F., Chiodini, P., Verde, N., Piscopo, M., Galdiero, G., Fraia, D. A. D., Mazzarella, A., Paola, N. D., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-03037-5
Persu, C., CIOFU, I., Proca, T. M., Popescu, G. S., Cartas, R. N., Chirca, N., & Cauni, V. (2026) · Biomedicines · doi:10.3390/biomedicines14112546
Hormones, glycaemia and innate immunity: correlates of NK cell dysfunction in type 2 diabetes
Omer, Z., Cai, H.-Q., & Dawood, A. (2026) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2026-0069
Kemp, T. (2014) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.